1,311 results on '"Real, Francisco X."'
Search Results
2. The urothelial gene regulatory network: understanding biology to improve bladder cancer management
3. Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
4. List of contributors
5. NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation
6. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
7. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities
8. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
9. Comparison of spatial transcriptomics technologies across six cancer types
10. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
11. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
12. What is a Bladder Cancer Molecular Subtype? – Counterpoint
13. Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
14. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
15. The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
16. Bptf determines oncogenic addiction in aggressive B-cell lymphomas
17. Animal Modeling of Pancreatitis-to-Cancer Progression
18. Mouse Models Shed Light on the SLIT/ROBO Pathway in Pancreatic Development and Cancer
19. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
20. The urothelial gene regulatory network: understanding biology to improve bladder cancer management
21. HNF1A plays a context-dependent role in pancreatic cancer initiation and progression
22. The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers
23. Integration of metabolome and microbiome omics layers toward pancreatic cancer risk prediction
24. Complement system genetic variability shapes pancreatic cancer risk
25. Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
26. Data from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
27. Figure S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
28. Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
29. Supplementary Table S6 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
30. Data from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
31. Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe
32. PDAC heterogeneity resolved spatially at the single‐cell level: new biological answers, new questions on optimal translation†.
33. Total Fluid and Water Consumption and the Joint Effect of Exposure to Disinfection by-Products on Risk of Bladder Cancer
34. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
35. Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features
36. Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
37. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
38. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
39. Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’
40. GalNAc-α-O-Benzyl Inhibits NeuAcα2-3 Glycosylation and Blocks the Intracellular Transport of Apical Glycoproteins and Mucus in Differentiated HT-29 Cells
41. Data from Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
42. Supplementary Data from Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
43. Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
44. Abstract 6075: Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing
45. Supplementary Figure 2 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
46. Supplementary Figure 4 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
47. Supplementary Figure 6 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
48. Supplementary Figure 1 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
49. Data from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
50. Supplementary Figure 3 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.